The National Immunisation Programme in the Netherlands 2013 - 2014 Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).
Point-of-care testing in nursing homes in the Netherlands RIVM has conducted an explorative study on the use of point-of-care (POC) tests in nursing homes.
Personalised medicine provides optimal treatment In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach
Ebola information for GPs RIVM has sent a message to Community Health Services (GGD's) containing information about how issues concerning Ebola are arranged in the Netherlands.
Possibly more cases of gastroenteritis caused by antacids In recent years the Netherlands has witnessed an increase in the number of cases of gastroenteritis caused by the Campylobacter bacterium.
Annual report RIVM 2013 online In our annual report, we look back at compelling RIVM projects and research in 2013.
Ongoing Ebola outbreak West Africa August 8th the World Health Organization declared the Ebola outbreak in West Africa an international health emergency and appealed for global aid to help afflicted countries.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Breast milk as indicator of environmental pollutants The 6th worldwide study into Persistent Organic Pollutants (POPs) in breast milk is about to commence.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).